This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Illinois. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations by Jeffrey Jacobson in Pulmonary Disease Treatment
Introduction
Jeffrey Jacobson is an accomplished inventor based in Oak Park, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pulmonary diseases. His innovative approach has led to the development of a unique method that addresses critical health issues.
Latest Patents
Jacobson holds a patent for a "Method of preventing or treating a pulmonary disease or condition." This patent involves a pharmaceutical composition designed for aerosol administration, utilizing a SphK1 inhibitor to effectively prevent or treat pulmonary diseases in subjects. This innovative method showcases his commitment to advancing medical treatments.
Career Highlights
Jacobson is affiliated with the University of Illinois, where he continues to engage in research and development. His work is characterized by a focus on improving health outcomes through innovative pharmaceutical solutions. With 1 patent to his name, he has established himself as a notable figure in the field of medical research.
Collaborations
Throughout his career, Jacobson has collaborated with esteemed colleagues, including Viswanathan Natarajan and Roberto F Machado. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Jeffrey Jacobson's contributions to the treatment of pulmonary diseases through innovative pharmaceutical methods highlight his dedication to improving healthcare. His work at the University of Illinois and his patent demonstrate the potential for significant advancements in medical treatments.